tiprankstipranks
IceCure Medical management to meet with Oppenheimer
PremiumThe FlyIceCure Medical management to meet with Oppenheimer
11d ago
IceCure Medical management to meet with Oppenheimer
PremiumThe Fly
IceCure Medical management to meet with Oppenheimer
15d ago
Icecure Medical in Jeopardy: Navigating Nasdaq Delisting Risks and Future Uncertainties
PremiumCompany Announcements
Icecure Medical in Jeopardy: Navigating Nasdaq Delisting Risks and Future Uncertainties
22d ago
IceCure Medical price target raised to $2.90 from $1.90 at Alliance Global Partners
PremiumThe FlyIceCure Medical price target raised to $2.90 from $1.90 at Alliance Global Partners
1M ago
IceCure Medical Triumphs in Breast Cancer Study
PremiumCompany Announcements
IceCure Medical Triumphs in Breast Cancer Study
1M ago
IceCure Medical’ reports positive topline results for breast tumor cryoablation
PremiumThe Fly
IceCure Medical’ reports positive topline results for breast tumor cryoablation
1M ago
IceCure Medical Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
PremiumPress ReleasesIceCure Medical Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
3M ago
IceCure Medical regains compliance with Nasdaq minimum closing bid price rule
PremiumThe Fly
IceCure Medical regains compliance with Nasdaq minimum closing bid price rule
3M ago
IceCure Medical sees FY23 ProSense sales up 26% globally
PremiumThe Fly
IceCure Medical sees FY23 ProSense sales up 26% globally
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100